Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Statistics

Total Valuation

CRVS has a market cap or net worth of $1.51 billion. The enterprise value is $1.45 billion.

Market Cap	1.51B
Enterprise Value	1.45B

Important Dates

The next estimated earnings date is Tuesday, March 24, 2026, after market close.

Earnings Date	Mar 24, 2026
Ex-Dividend Date	n/a

Share Statistics

CRVS has 83.77 million shares outstanding. The number of shares has increased by 34.14% in one year.

Current Share Class	83.77M
Shares Outstanding	83.77M
Shares Change (YoY)	+34.14%
Shares Change (QoQ)	+6.51%
Owned by Insiders (%)	2.35%
Owned by Institutions (%)	47.33%
Float	72.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	18.94
P/TBV Ratio	21.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.29, with a Debt / Equity ratio of 0.01.

Current Ratio	8.29
Quick Ratio	8.18
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -35.82% and return on invested capital (ROIC) is -56.78%.

Return on Equity (ROE)	-35.82%
Return on Assets (ROA)	-34.87%
Return on Invested Capital (ROIC)	-56.78%
Return on Capital Employed (ROCE)	-53.67%
Weighted Average Cost of Capital (WACC)	8.36%
Revenue Per Employee	n/a
Profits Per Employee	-$486,290
Employee Count	31
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +360.28% in the last 52 weeks. The beta is 0.75, so CRVS's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+360.28%
50-Day Moving Average	14.23
200-Day Moving Average	7.92
Relative Strength Index (RSI)	53.31
Average Volume (20 Days)	1,541,384

Short Selling Information

The latest short interest is 14.68 million, so 17.52% of the outstanding shares have been sold short.

Short Interest	14.68M
Short Previous Month	11.49M
Short % of Shares Out	17.52%
Short % of Float	20.39%
Short Ratio (days to cover)	2.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.86M
Pretax Income	-15.08M
Net Income	-15.08M
EBITDA	-38.76M
EBIT	-38.86M
Earnings Per Share (EPS)	-$0.56

Balance Sheet

The company has $65.69 million in cash and $1.01 million in debt, with a net cash position of $64.68 million or $0.77 per share.

Cash & Cash Equivalents	65.69M
Total Debt	1.01M
Net Cash	64.68M
Net Cash Per Share	$0.77
Equity (Book Value)	71.77M
Book Value Per Share	0.96
Working Capital	58.87M

Cash Flow

In the last 12 months, operating cash flow was -$32.07 million and capital expenditures -$149,000, giving a free cash flow of -$32.22 million.

Operating Cash Flow	-32.07M
Capital Expenditures	-149,000
Free Cash Flow	-32.22M
FCF Per Share	-$0.38

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.14%
Shareholder Yield	-34.14%
Earnings Yield	-0.99%
FCF Yield	-2.13%

Analyst Forecast

The average price target for CRVS is $28.00, which is 54.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.00
Price Target Difference	54.91%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1